Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chia-Kuei Mo

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Biointerphases|May 29, 2016
Creating cellular patterns using genetically engineered, gold- and cell-binding polypeptidesLinying Li, Chia-Kuei Mo, Ashutosh Chilkoti, et al.
Biomacromolecules|December 3, 2017
Functional Modification of Silica through Enhanced Adsorption of Elastin-Like Polypeptide Block CopolymersLinying Li, Nan K Li, Qing Tu, et al.
Cell Reports|January 26, 2025
The spatial landscape of cancer hallmarks reveals patterns of tumor ecological dynamics and drug sensitivityMustafa Sibai, Sergi Cervilla, Daniela Grases, et al.
Nature Genetics|April 21, 2025
Multi-omic and spatial analysis of mouse kidneys highlights sex-specific differences in gene regulation across the lifespanSiqi Chen, Ruiyang Liu, Chia-Kuei Mo, et al.
Nature Communications|March 21, 2024
Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancerAshenafi Bulle, Peng Liu, Kuljeet Seehra, et al.
Nature Communications|May 17, 2023
Author Correction: Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinomaYige Wu, Nadezhda V Terekhanova, Wagma Caravan, et al.
Nature Communications|March 27, 2023
Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinomaYige Wu, Nadezhda V Terekhanova, Wagma Caravan, et al.
Cancer Research|December 15, 2023
Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell CarcinomaYige Wu, Siqi Chen, Xiaolu Yang, et al.
Nature|November 2, 2023
Epigenetic regulation during cancer transitions across 11 tumour typesNadezhda V Terekhanova, Alla Karpova, Wen-Wei Liang, et al.
Nature|October 31, 2024
Tumour evolution and microenvironment interactions in 2D and 3D spaceChia-Kuei Mo, Jingxian Liu, Siqi Chen, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Biointerphases|May 29, 2016
Creating cellular patterns using genetically engineered, gold- and cell-binding polypeptidesLinying Li, Chia-Kuei Mo, Ashutosh Chilkoti, et al.
Biomacromolecules|December 3, 2017
Functional Modification of Silica through Enhanced Adsorption of Elastin-Like Polypeptide Block CopolymersLinying Li, Nan K Li, Qing Tu, et al.
Cell Reports|January 26, 2025
The spatial landscape of cancer hallmarks reveals patterns of tumor ecological dynamics and drug sensitivityMustafa Sibai, Sergi Cervilla, Daniela Grases, et al.
Nature Genetics|April 21, 2025
Multi-omic and spatial analysis of mouse kidneys highlights sex-specific differences in gene regulation across the lifespanSiqi Chen, Ruiyang Liu, Chia-Kuei Mo, et al.
Nature Communications|March 21, 2024
Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancerAshenafi Bulle, Peng Liu, Kuljeet Seehra, et al.
Nature Communications|May 17, 2023
Author Correction: Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinomaYige Wu, Nadezhda V Terekhanova, Wagma Caravan, et al.
Nature Communications|March 27, 2023
Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinomaYige Wu, Nadezhda V Terekhanova, Wagma Caravan, et al.
Cancer Research|December 15, 2023
Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell CarcinomaYige Wu, Siqi Chen, Xiaolu Yang, et al.
Nature|November 2, 2023
Epigenetic regulation during cancer transitions across 11 tumour typesNadezhda V Terekhanova, Alla Karpova, Wen-Wei Liang, et al.
Nature|October 31, 2024
Tumour evolution and microenvironment interactions in 2D and 3D spaceChia-Kuei Mo, Jingxian Liu, Siqi Chen, et al.
Pageof 2